Aspirin and colorectal cancer.

This publication has 12 references indexed in Scilit:

• Effect of aspirin and non-steroidal anti-inflammatory drugs on colorectal adenomas: case-control study of subjects participating in the Nottingham faecal occult blood screening programme.
  BMJ, 1993
• Aspirin Use and Reduced Risk of Fatal Colon Cancer
  New England Journal of Medicine, 1991
• Aspirin Use and Incidence of Large-Bowel Cancer in a California Retirement Community
  JNCI Journal of the National Cancer Institute, 1991
• Aspirin use and chronic diseases: a cohort study of the elderly.
  BMJ, 1989
• Secondary prevention of vascular disease by prolonged antiplatelet treatment
  BMJ, 1988
• Randomised trial of prophylactic daily aspirin in British male doctors
  BMJ, 1988
• 16,16-Dimethyl prostaglandin E2 suppresses the increases in the proliferative activity of rat colonic epithelium induced by indomethacin and aspirin
  Gastroenterology, 1985
• Reduction of carcinogenicity of N-nitrosomethylurea by indomethacin and failure of resuming effect of prostaglandin E2 (PGE2) against indomethacin
  Zeitschrift für Krebsforschung und Klinische Onkologie, 1984
• Enhancement of T lumphocyte proliferative response to mitogens by indomethacin in breast and colorectal cancer patients
  International Journal of Immunopharmacology, 1983
• Analgesic Nephropathy
  Drugs, 1982